Results 281 to 290 of about 112,075 (306)

Immune cell-mediated features of non-alcoholic steatohepatitis

Nature Reviews Immunology, 2021
Thierry Huby, Emmanuel L Gautier
exaly  

Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial

Nature Medicine, 2021
Erik J Tillman, Kitty Yale
exaly  

Non-alcoholic fatty liver disease

Lancet, The, 2021
Elizabeth E Powell, Vincent Wai-Sun Wong, Mary E Rinella   +2 more
exaly  

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Nature Medicine, 2021
Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez   +2 more
exaly  

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

Nature Medicine, 2021
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori   +2 more
exaly  

Alcoholic Hepatitis

Clinics in Gastroenterology, 1981
openaire   +2 more sources

Gut microbiota in human metabolic health and disease

Nature Reviews Microbiology, 2020
Yong Fan, Oluf Borbye Pedersen
exaly  

Alcoholic hepatitis

The Lancet, 1994
openaire   +2 more sources

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity

Nature Metabolism, 2021
Herbert Tilg, , Michael Dudek
exaly  

Alcoholic liver disease: mechanisms of injury and targeted treatment

Nature Reviews Gastroenterology and Hepatology, 2015
Alexandre Louvet, Philippe Mathurin
exaly